NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Progenity Inc (NASDAQ: PROG)

PROG Technical Analysis
As on 6th Dec 2021 PROG Share Price closed @ 2.82 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.24 & Strong Sell for SHORT-TERM with Stoploss of 5.80 we also expect STOCK to react on Following IMPORTANT LEVELS.

PROG Share Price

Open 2.24 Change Price %
High 2.88 1 Day 0.46 19.49
Low 2.13 1 Week -0.93 -24.80
Close 2.82 1 Month -0.14 -4.73
Volume 43275793 1 Year -6.47 -69.64
52 Week High 9.48 | 52 Week Low 0.67
NASDAQ USA Most Active Stocks
AAPL 165.32 2.15%
LCID 44.86 -5.10%
SNDL 0.57 1.79%
ISIG 15.05 204.66%
CFVI 12.70 6.72%
AAL 17.93 7.88%
ARDX 1.38 -9.21%
AMD 139.06 -3.44%
NVDA 300.37 -2.14%
ACET 13.57 38.47%
NASDAQ USA Top Gainers Stocks
TPGY-WT 10.16 636.23%
ISIG 15.05 204.66%
NVNOW 0.33 73.68%
TACO 12.51 66.14%
CPIX 6.94 51.20%
ACET 13.57 38.47%
VYNE 1.20 31.87%
BOWXW 2.97 29.13%
EFTR 7.37 29.07%
OXBRW 0.50 28.21%
NASDAQ USA Top Losers Stocks
HEC 0.00 -100.00%
HEC 0.00 -100.00%
HEC 0.00 -100.00%
ADMS 0.00 -100.00%
THMA 0.49 -94.73%
PTRAW 0.23 -89.59%
SGOC 4.95 -55.84%
BOLT 4.64 -55.81%
BOLT 4.64 -55.81%
BOLT 4.64 -55.81%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
PROG Important Levels Intraday
PROG Target for Month December
4th UP TARGET13.65
3rd UP TARGET10.18
2nd UP TARGET8.03
1st UP TARGET5.88
1st DOWN TARGET-0.24
2nd DOWN TARGET-2.39
3rd DOWN TARGET-4.54
4th DOWN TARGET-8.01
PROG Weekly Target
4th UP TARGET4.40
3rd UP TARGET3.89
2nd UP TARGET3.58
1st UP TARGET3.27
PROG Target for Year 2021
4th UP TARGET19.97
3rd UP TARGET14.47
2nd UP TARGET11.07
1st UP TARGET7.67
1st DOWN TARGET-2.03
2nd DOWN TARGET-5.43
3rd DOWN TARGET-8.83
4th DOWN TARGET-14.33
PROG Other Details
Segment EQ
Market Capital 513703776.00
Sector Healthcare
Industry Biotechnology
Offical website >
PROG Address
PROG Latest News
Your Comments and Response on Progenity Inc
PROG Business Profile
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated with inherited risk of 12 types of cancers, including the BRCA1/2 genes for hereditary breast, ovarian, colorectal, endometrial, pancreatic, and other cancer syndromes, as well as for the five genes associated with Lynch syndrome. The company also provides Resura, a noninvasive prenatal test for families at risk for rare single gene disorders; and Preecludia, a preeclampsia rule-out test. In addition, it offers anatomic and molecular pathology tests, and COVID-19 PCR testing services, as well as test products that includes chromosomal microarray for pregnancy loss, which evaluates the genetic cause of miscarriage; maternal serum screening for chromosomal disorders; and preimplantation genetic testing for use with artificial reproductive technologies. Further, the company develops therapeutic solutions for gastrointestinal-related disorders, such as PGN-001, PGN-300, PGN-600, and PGN-OB2. It also owns and operates laboratory. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California. Address: 4330 La Jolla Village Drive, San Diego, CA, United States, 92122
2005-2021 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service